EICHOR
● Completed
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
Condition: Schizophrenia · Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
About this study
This is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequate response to their current atypical antipsychotic treatment. The primary objective of the study is to assess the efficacy of adjunctive KarXT (a fixed dose combination of xanomeline and trospium chloride twice daily \[BID\]) versus placebo in the treatment of subjects with inadequately controlled symptoms of schizophrenia as measured by the Positive and Negative Syndrome Scale (PANSS) Total Score.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (166)
| IMA Clinical Research | Phoenix, Arizona, United States | — |
| Local Institution - 147 | Phoenix, Arizona, United States | — |
| Pillar Clinical Research, LLC | Little Rock, Arkansas, United States | — |
| Woodland International Research Group, LLC | Little Rock, Arkansas, United States | — |
| Advanced Research Center, Inc. | Anaheim, California, United States | — |
| CITrials - Bellflower | Bellflower, California, United States | — |
| Synexus Clinical Research US, Inc. | Cerritos, California, United States | — |
| Clinical Innovations Inc. | Costa Mesa, California, United States | — |
| Proscience Research Group | Culver City, California, United States | — |
| CenExel Collaborative Neuroscience Research | Garden Grove, California, United States | — |
| Omega Clinical Trials | La Habra, California, United States | — |
| Sunwise Clinical Research, LLC. | Lafayette, California, United States | — |
+ 154 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05145413